New pill shows promise against rare bile duct cancer in Late-Stage trial
NCT ID NCT07328919
First seen Jan 11, 2026 · Last updated May 14, 2026 · Updated 21 times
Summary
This study tests a new oral drug, TT-00420, against standard chemotherapy for people with advanced bile duct cancer that has a specific genetic change (FGFR2). The trial includes 138 adults whose cancer worsened after initial treatment. The goal is to see if the new drug can slow cancer growth better than chemo.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTRAHEPATIC CHOLANGIOCARCINOMA (ICC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Anhui Provincial Hospital
Hefei, Anhui, China
-
Beijing Cancer Hospital
Beijing, China
Contact
-
Beijing Tsinghua Changgung Hospital
Beijing, China
-
Cancer Hospital, Chinese Academy of Medical Sciences
Beijing, China
-
Eastern Hepatobiliary Surgery Hospital
Shanghai, China
-
Fudan University Shanghai Cancer Hospital
Shanghai, China
-
Fujian Cancer Hospital
Fuzhou, Fujian, China
-
Hunan Cancer Hospital
Changsha, Hunan, China
-
Jinan Central Hospital
Jinan, Shandong, China
-
Nanjing Drum Tower Hospital
Nanjing, Jiangsu, China
-
Peking Union Medical College Hospital
Beijing, China
-
Shandong Cancer Hospital
Jinan, Shandong, China
-
Sichuan Cancer Hospital
Chengdu, Sichuan, China
-
The First Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, China
-
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, China
-
West China Hospital of Sichuan University
Chengdu, Sichuan, China
-
Zhejiang Cancer Hospital
Hangzhou, Zhejiang, China
-
Zhongnan hospital of Wuhan University
Wuhan, Hubei, China
-
Zhongshan Hospital, Fudan University
Shanghai, China
-
Zhujiang Hospital of Southern Medical University
Guangzhou, Guangdong, China
Conditions
Explore the condition pages connected to this study.